A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with CAD.
From an ethical perspective, disclosing adverse events to patients is predicated on the idea that physicians have obligations to tell the truth, but physicians may worry that apologizing will incur greater responsibility for liability.
The use of telemedicine has been surging since the onset of coronavirus disease 2019 (COVID-19), with millions of Americans now using this medium for connecting with their clinicians.
It is certainly too early to know if there will be any seasonal variation to SARS-CoV-2 infection, and there is no reason to specifically compare this virus with the seasonal behavior of influenza virus or to other seasonal respiratory viruses.
Recent reports have indicated an association between a Kawasaki-like disease and COVID-19 in pediatric populations. Mary Beth Son, MD, of the Boston Children’s Hospital weighs in.
Mitigating the spread of a virus as infectious as SARS-CoV-2, the virus which causes COVID-19, requires having ample and accurate diagnostic tests available. However, in the United States community transmission began to occur before adequate testing measures could be implemented.
To shed light on how clinical practice is dealing in this time of COVID-19, we spoke with Jesse Clark, DO, Associate Program Director of Education at the Community East Family Medicine Residency and Clinical Chairperson of Family Medicine at Marian University College of Osteopathic Medicine, Indianapolis, Indiana.
The use of telemedicine has been surging since the onset of coronavirus disease 2019 (COVID-19), with millions of Americans now using this medium for connecting with their clinicians.
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
